Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBaseFabrizio Calapai, Carmen Mannucci, Liana McQuain, et al.
Natural Product Research|September 12, 2022
Asian herbal medicine and chronic urticaria: which are the therapeutic perspectives?Luca Gammeri, Claudia Panzera, Fabrizio Calapai, et al.
Phytotherapy Research : PTR|October 18, 2016
Clinical Pharmacology of Citrus bergamia: A Systematic ReviewCarmen Mannucci, Michele Navarra, Fabrizio Calapai, et al.
International Journal of Molecular Sciences|August 27, 2021
Involvement of Alarmins in the Pathogenesis and Progression of Multiple MyelomaGiuseppe Murdaca, Alessandro Allegra, Francesca Paladin, et al.
Pharmacology|September 9, 2014
Montelukast-induced adverse drug reactions: a review of case reports in the literatureGioacchino Calapai, Marco Casciaro, Marco Miroddi, et al.
CNS Neuroscience & Therapeutics|May 20, 2014
Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's diseaseMarco Miroddi, Michele Navarra, Maria C Quattropani, et al.
Frontiers in Pharmacology|February 27, 2023
Pharmacovigilance on cannabidiol as an antiepileptic agentIlaria Ammendolia, Carmen Mannucci, Luigi Cardia, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilanceFabrizio Calapai, Carmen Mannucci, Mariaconcetta Currò, et al.
Pharmacology Research & Perspectives|August 24, 2023
Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distributionFabrizio Calapai, Carmen Mannucci, Luigi Cardia, et al.
Pageof 5